Transplant Diagnostics Market by Product & Services (Reagents & Consumables, Software & Services, Instruments), Technology (Molecular Assay Technology, Non-Molecular Assay Technology), Application (Diagnostic Applications, Research Applications), Transplant Type (Stem Cell Transplantation, Soft Tissue Transplantation and, Solid Organ Transplantation), End User (Research Laboratories & Academic Institutions, Hospitals & Transplant Centers) - Analysis & Forecast 2019-2030

Report ID : 98  |  Published Date : May 2019  |  Pages : 150  |  Region : global  |  Report Code : BT-18




Transplant Diagnostics Market Overview and Introduction

The Global Transplant Diagnostics Market is estimated to be over US$ 3.40 Billion in 2018. It is anticipated to grow At a Double Digit CAGR from 2019 to 2030. 

Transplantation is defined as the surgical procedure of transferring damaged cells, tissues or organs called a graft, from one individual and placing them into a same or different individual.  Diagnostics tests in transplantations play an important role in checking, rejection monitoring and Human Leukocyte Antigen (HLA). The transplantation diagnostics tests aid in the detection of HLA compatibility between the donor and recipient before transplantation procedures. These tests are used to monitor transplanted organs post-surgery for rejection. On the basis of source of transplant organ, transplant diagnostics are categorized into autografts, allografts and xenografts.

The global transplantation diagnostics market is driven by increase in geriatric population, rising applications of HLA typing products in clinical diagnostics, increasing awareness regarding organ transplantation, improving healthcare infrastructure, rising prevalence of chronic diseases and technological advancements. Moreover, continuous decrease in the average cost of gene sequencing, rising number of soft tissue transplantations and increasing installed base of PCR and NGS instruments is supporting the growth of this market. However, the high cost of transplantation procedures coupled with limited reimbursement of transplantation procedures is likely to restrain the market.

Transplant Diagnostics Market by Product & Services

On the basis of product and services, the market is segmented into reagents & consumables, software & services and instruments. The reagents & consumables segment is expected to account for the largest share of this market owing to factors such as rising number of organ transplantation procedures, growing adoption of transplantation techniques.

Transplant Diagnostics Market by Technology

Based on technology, the market is divided into molecular assay technologies and non-molecular assay technologies. Molecular assay technologies are further divided into PCR-based molecular assay technologies and sequencing based molecular assay technologies. PCR-based molecular assay technologies are subcategorized into real-time PCR, sequence-specific oligonucleotide-PCR, sequence specific primer and other PCR technologies. Sequencing-based molecular assay technologies are subdivided into Sanger sequencing, next generation sequencing and other sequencing technologies. The molecular assay technology segment is anticipated to hold the largest share of this market due to increasing capital for the development of advanced transplant diagnostics products.

Transplant Diagnostics Market by Application

On the basis of application, the market is classified into diagnostic applications and research applications. The diagnostic applications segment is further classified into pre-transplantation applications and post-transplantation applications. The diagnostics applications segment is expected to dominate the market owing to the factors such as rising prevalence of chronic diseases and major risk of genetic diseases after transplantation.

Transplant Diagnostics Market by Transplant Type

Based on transplant type, the market is segmented into stem cell transplantation, soft tissue transplantation and solid organ transplantation. The government initiatives to support organ donation, increasing number of chronic disorders are the factors supporting the growth of the market.

Transplant Diagnostics Market by End Users

On the basis of end user, the market is categorized into research laboratories & academic institutions and hospitals & transplant centers.

Transplant Diagnostics Market by Region

The global market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of transplant diagnostics, followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such as higher healthcare expenses, large demand for the advanced techniques and diagnostics tools and increase in geriatric population. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered in China, India. Factors such as major pool of patients, improving healthcare infrastructure and investment in stem cells are likely to attract patients from different parts of the world.

Transplant Diagnostics Market Prominent Players

The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, IVD Holdings, Inc., Gendx, Luminex Corporation and, Omixon Inc. among others.

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.  Market Classification
      2.  Geographic Scope
      3.  Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1.  Bottoms Up Approach
      2.  Top Down Approach
    5. Data Validation and Triangulation
      1.  Market Forecasting Model
      2.  Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Regulatory Landscape Assessment
    2. Technological Advancements
    3. Organ Transplant Assessment, By Region
  6. GLOBAL TRANSPLANT DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY PRODUCT & SERVICES
    1. Reagents & Consumables
    2. Software & Services
    3. Instruments
  7. GLOBAL TRANSPLANT DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
    1. Molecular Assay Technologies
      1. PCR-Based Molecular Assay Technologies
        1. Real-Time PCR
        2. Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
        3. Sequence-Specific Primer-PCR (SSP-PCR)
        4. Other PCR technologies
      2.   Sequencing-Based Molecular Assay Technologies
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Other Sequencing Technologies
    2. Non-Molecular Assay Technologies
  8. GLOBAL TRANSPLANT DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Diagnostic Applications
      1. Pre-Transplantation   
      2. Post-Transplantation
    2. Research Applications
  9. GLOBAL TRANSPLANT DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY TRANSPLANT TYPE
    1. Stem Cell Transplantation
    2. Soft Tissue Transplantation
    3. Solid Organ Transplantation
      1. Heart
      2. Lung
      3. Liver
      4. Kidney
      5. Pancreas
      6. Others
  10. GLOBAL TRANSPLANT DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY END USER
    1. Research Laboratories and Academic Institutions
    2. Hospitals and Transplant Centers
    3. Others
  11. GLOBAL MARKET - ANALYSIS & FORECAST, BY REGION
    1.   North America Transplant Diagnostics Market
      1.  North America Market, By Country
        1. US
        2.  Canada
      2. North America Market Analysis & Forecast, By Product  & Services
      3. North America Market Analysis & Forecast, By Technology
      4. North America Market Analysis & Forecast, By Application
      5. North America Market Analysis & Forecast, By Transplant Type
      6. North America Market Analysis & Forecast, By End User
    2.   Europe Transplant Diagnostics Market
      1. Europe Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Market Analysis & Forecast, By Product  & Services
      3. Europe Market Analysis & Forecast, By Technology
      4. Europe Market Analysis & Forecast, By Application
      5. Europe Market Analysis & Forecast, By Transplant Type
      6. Europe Market Analysis & Forecast, By End User
    3. Asia Pacific Transplant Diagnostics Market
      1. Asia Pacific Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Market Analysis & Forecast, By Product  & Services
      3. Asia Pacific Market Analysis & Forecast, By Technology
      4. Asia Pacific Market Analysis & Forecast, By Application
      5. Asia Pacific Market Analysis & Forecast, By Transplant Type
      6. Asia Pacific Market Analysis & Forecast, By End User
    4.   Rest of the World (ROW) Transplant Diagnostics Market
      1. Rest of the World Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Market Analysis & Forecast, By Product  & Services
      3. Rest of the World Market Analysis & Forecast, By Technology
      4. Rest of the World Market Analysis & Forecast, By Application
      5. Rest of the World Market Analysis & Forecast, By Transplant Type
      6. Rest of the World Market Analysis & Forecast, By End User
  12. COMPETETIVE LANDSCAPE
    1. Market Share Analysis (2018)
    2. Key Strategies Assessment
      1. New Product & Services Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  13. COMPANY PROFILES (Business Overview, Products & Services Offered, Financial Performance*, Recent Developments)
    1. Bio-Rad Laboratories, Inc.
    2. Thermo Fisher Scientific Inc.
    3. QIAGEN
    4. F. Hoffmann-La Roche Ltd.
    5. Illumina, Inc.
    6. Merck KGaA
    7. IVD Holdings, Inc.
    8. Gendx
    9. Luminex Corporation
    10. Omixon Inc.

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain